Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report

Clin Colorectal Cancer. 2021 Dec;20(4):364-367. doi: 10.1016/j.clcc.2021.09.002. Epub 2021 Sep 15.

¹ Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: [email protected].
² Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
³ Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
⁴ Università Cattolica del Sacro Cuore, Rome, Italy; Anatomia Patologica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
⁵ Università Cattolica del Sacro Cuore, Rome, Italy; Chirurgia Epato-biliare, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

No abstract available

Keywords: BRAF mutation; CRC; Liver surgery; Precision oncology; Target therapy.

Publication types